Bachem Holding AG (BHM)
XDUS
Closed
Aug 24, 2026
Day's Range
7.3052 wk Range
4.56Overview - BHM - Bachem Holding AG
Key Statistics
Valuation
P/E (Trailing)
‪38.13‬
Profitability
Profit Margin
‪28.73%‬
Operating Margin
‪22.55%‬
Return on Assets
‪7.05%‬
Return on Equity
‪10.20%‬
Ownership
Shares Outstanding
74.93M
Price stats
50-Day Avg
‪7.44‬
200-Day Avg
‪6.50‬
Dividends
Frequency
Annual
Shariah Compliance
Report Date: Feb 18, 2025
Screened by Zoya using the AAOIFI methodology.
Peers - BHM - Bachem Holding AG
Peer Comparison
Compared with companies in Biotechnology listed on XDUS.
- BHMXDUSBachem Holding AG+8.51%52-week change35.61P/E (Trailing)‪28.73%‬Profit Margin
- 4E2XDUSRelmada Therapeutics Inc.+86.32%52-week change-2.62P/E (Trailing)—Profit Margin
- 3920XDUSSpyre Therapeutics, Inc.+84.37%52-week change-46.21P/E (Trailing)—Profit Margin
- 42ZXDUSRevolution Medicines Inc.+82.81%52-week change-30.12P/E (Trailing)—Profit Margin
- 87EXDUSDianthus Therapeutics Inc.+78.20%52-week change-22.50P/E (Trailing)—Profit Margin
- 5NRAXDUSNanobiotix S.A. American Depositary Shares+77.55%52-week change—P/E (Trailing)—Profit Margin
- 5NRXDUSNanobiotix S.A.+77.54%52-week change—P/E (Trailing)—Profit Margin
Profile Summary - BHM - Bachem Holding AG
About
Bachem Holding AG is a leading player in the biotechnology and pharmaceuticals industry. It specializes in the development, manufacturing, and commercialization of peptides and related products. These biomolecules are crucial components in drug development, serving as active pharmaceutical ingredients (APIs) that…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
